Publications by authors named "Ibukunoluwa Ogunbowale"
Medicine (Baltimore)
May 2024
Article Synopsis
- Ovarian cancer is a leading cause of death among gynecologic cancers, and this paper investigates the use of mirvetuximab soravtansine, a targeted therapy for platinum-resistant ovarian cancer expressing folate receptor alpha (FRα).
- Four key studies involving 453 participants show that mirvetuximab soravtansine is effective in fighting tumors with a good safety profile, particularly beneficial for tumors with high FRα expression.
- While the treatment shows promise for enhancing therapy outcomes, further research is needed to address patient diversity, improve quality of life data, and understand long-term safety, as well as to identify more biomarkers for personalized treatment options.
